3/27
02:06 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Low
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
3/25
04:01 pm
acor
Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
Low
Report
Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024
3/19
02:08 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Low
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
3/11
09:04 am
acor
Klick Health Launches First AI Social Media Comment Moderator for Life Sciences Industry [Yahoo! Finance]
Medium
Report
Klick Health Launches First AI Social Media Comment Moderator for Life Sciences Industry [Yahoo! Finance]
3/11
02:05 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Low
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
3/3
02:06 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Medium
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
2/24
02:04 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
High
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
2/16
01:08 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Low
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
2/8
04:08 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Neutral
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
2/1
11:25 am
acor
Spinal Cord Trauma Treatment Market Global Industry Analysis Through 2031: In-depth Analysis of Therapeutic Advances and Emerging Trends [Yahoo! Finance]
Neutral
Report
Spinal Cord Trauma Treatment Market Global Industry Analysis Through 2031: In-depth Analysis of Therapeutic Advances and Emerging Trends [Yahoo! Finance]
1/31
01:07 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Low
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
1/24
08:15 am
acor
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer [Yahoo! Finance]
Medium
Report
ZWI Therapeutics, Inc. Announces a Series A Financing, Two Accomplished Biopharmaceutical CEOs Join the Board of Directors, and Appointment of Chief Executive Officer [Yahoo! Finance]
1/24
05:12 am
acor
Dry Powder Inhaler Devices Pipeline Analysis Report 2023: Stages of Development, Regulatory Pathways, Key Companies, Regional Insights [Yahoo! Finance]
Medium
Report
Dry Powder Inhaler Devices Pipeline Analysis Report 2023: Stages of Development, Regulatory Pathways, Key Companies, Regional Insights [Yahoo! Finance]
1/23
01:04 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Medium
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
1/17
01:10 pm
acor
2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies [Yahoo! Finance]
Low
Report
2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies [Yahoo! Finance]
1/15
01:08 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
High
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
1/11
08:03 am
acor
Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025 [Yahoo! Finance]
Medium
Report
Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025 [Yahoo! Finance]
1/11
08:01 am
acor
Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025
Medium
Report
Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025
1/7
01:09 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Medium
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
12/30
01:06 am
acor
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Medium
Report
Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.